April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA121
Academic Journal
To investigate risk factors of nodal involvement in submucosal invasive colorectal carcinoma, scientists have examined the relationship between nodal involvement and tumour status of VEGF expression and tumour sprouting along with clinicopathological factors. Results of the study suggest that combination of VEGF-C expression and tumour sprouting are useful in predicting nodal involvement in submucosal invasive colorectal carcinoma.


Related Articles

  • Genomic and gene expression signatures of radiation in medulloblastomas after low-dose irradiation in Ptch1 heterozygous mice. Ishida, Yuka; Takabatake, Takashi; Kakinuma, Shizuko; Doi, Kazutaka; Yamauchi, Kazumi; Kaminishi, Mutsumi; Kito, Seiji; Ohta, Yuki; Amasaki, Yoshiko; Moritake, Hiroyuki; Kokubo, Toshiaki; Nishimura, Mayumi; Nishikawa, Tetsu; Hino, Okio; Shimada, Yoshiya // Carcinogenesis;Sep2010, Vol. 31 Issue 9, p1694 

    Accurate cancer risk assessment of low-dose radiation poses many challenges that are partly due to the inability to distinguish radiation-induced tumors from spontaneous ones. To elucidate characteristic features of radiation-induced tumors, we analyzed 163 medulloblastomas that developed either...

  • Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification. Smith, M. J.; Culhane, A. C.; Donovan, M.; Coffey, J. C.; Barry, B. D.; Kelly, M. A.; Higgins, D. G.; Wang, J. H.; Kirwan, W. O.; Cotter, T. G.; Redmond, H. P. // British Journal of Cancer;4/27/2009, Vol. 100 Issue 9, p1452 

    Tumour stroma gene expression in biopsy specimens may obscure the expression of tumour parenchyma, hampering the predictive power of microarrays. We aimed to assess the utility of fluorescence-activated cell sorting (FACS) for generating cell populations for gene expression analysis and to...

  • Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy. Maus, M K H; Hanna, D L; Stephens, C L; Astrow, S H; Yang, D; Grimminger, P P; Loupakis, F; Hsiang, J H; Zeger, G; Wakatsuki, T; Barzi, A; Lenz, H-J // Pharmacogenomics Journal;Aug2015, Vol. 15 Issue 4, p354 

    Colorectal cancer (CRC) is a heterogeneous disease with genetic profiles and clinical outcomes dependent on the anatomic location of the primary tumor. How location has an impact on the molecular makeup of a tumor and how prognostic and predictive biomarkers differ between proximal versus distal...

  • A Gene Expression Classifier of Node-Positive Colorectal Cancer. Meeh, Paul F.; Farrell, Christopher L.; Croshaw, Randal; Crimm, Hampton; Miller, Samantha K.; Oroian, Dora; Kowli, Sangeeta; Jinyu Zhu; Carver, Wayne; Wensong Wu; Pena, Edsel; Buckhaults, Phillip J. // Neoplasia;Oct2009, Vol. 11 Issue 10, p1074 

    We used digital long serial analysis of gene expression to discover gene expression differences between node-negative and node-positive colorectal tumors and developed a multigene classifier able to discriminate between these two tumor types. We prepared and sequenced long serial analysis of...

  • Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patients. Hyunji Lee; Ji Hyun Kim; Sung Yeun Yang; Jihye Kong; Minkyung Oh; Dae Hoon Jeong; Jae-il Chung; Ki Beom Bae; Jin Yong Shin; Kwan Hee Hong; Inhak Choi // Journal of Cancer Research & Clinical Oncology;Sep2010, Vol. 136 Issue 9, p1445 

    To associate the global gene expression of B7/CD28 family transcripts with pathologic features of colon cancer, we determined the B7/CD28 family transcripts in peripheral blood mononuclear cells (PBMCs) from normal subjects and patients with adenomatous polyps and colon cancer, and correlated...

  • Gene expression signatures for colorectal cancer microsatellite status and HNPCC. Kruhøffer, M.; Jensen, J. L.; Laiho, P.; Dyrskjøt, L.; Salovaara, R.; Arango, D.; Birkenkamp-Demtroder, K.; Sørensen, F. B.; Christensen, L. L.; Buhl, L.; Mecklin, J-P; Järvinen, H.; Thykjaer, T.; Wikman, F. P.; Bech-Knudsen, F.; Juhola, M.; Nupponen, N. N.; Laurberg, S.; Andersen, C. L.; Aaltonen, L. A. // British Journal of Cancer;6/20/2005, Vol. 92 Issue 12, p2240 

    The majority of microsatellite instable (MSI) colorectal cancers are sporadic, but a subset belongs to the syndrome hereditary nonpolyposis colorectal cancer (HNPCC). Microsatellite instability is caused by dysfunction of the mismatch repair (MMR) system that leads to a mutator phenotype, and...

  • MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. Kah Hoong Chang; Mestdagh, Pieter; Vandesompele, Jo; Kerin, Michael J.; Miller, Nicola // BMC Cancer;2010, Vol. 10, p173 

    Background: Advances in high-throughput technologies and bioinformatics have transformed gene expression profiling methodologies. The results of microarray experiments are often validated using reverse transcription quantitative PCR (RT-qPCR), which is the most sensitive and reproducible method...

  • The AKT/I?B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-?B andß-catenin. Agarwal, Anju; Das, Kingshuk; Lerner, Natalia; Sathe, Swati; Cicek, Muzaffer; Casey, Graham; Sizemore, Nywana // Oncogene;2/3/2005, Vol. 24 Issue 6, p1021 

    Our laboratory has delineated that the phosphatidylinositol 3'kinase (PI3K)/AKT/I?B kinase (IKK) pathway positively regulates NF?B andß-catenin, both important transcriptional regulators in colorectal cancer (CRC). Therefore, we investigated the effect of inhibiting the PI3K/AKT/IKKapathway...

  • Concomitant Tumor Expression of EGFR and TATI/SPINK1 Associates with Better Prognosis in Colorectal Cancer. Koskensalo, Selja; Louhimo, Johanna; Hagström, Jaana; Lundin, Mikael; Stenman, Ulf-Håkan; Haglund, Caj // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background: Epidermal growth factor receptor (EGFR) activation plays a role in colorectal cancer (CRC) carcinogenesis, and anti-EGFR drugs are used in treatment of advanced CRC. One of the EGFR ligands is tumor-associated trypsinogen inhibitor TATI, also called serine protease inhibitor Kazal...


Read the Article


Sign out of this library

Other Topics